Therefore, while procalcitonin and CRP can complement clinical assessments for initiating or discontinuing antibiotic treatment, further evidence is essential to substantiate their role in distinguishing bacterial co-infection in hospitalized patients with COVID-19. Here, CRP is linked to COVID-19.